Related Experiment Video
Updated: Apr 13, 2026

Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates
Published on: March 6, 2019
Synthesis and QSAR study of novel anti-inflammatory active mesalazine-metronidazole conjugates
Roman N Naumov1, Siva S Panda1, Adel S Girgis2
1Center for Heterocyclic Compounds, Department of Chemistry, University of Florida, Gainesville, FL 32611-7200, United States.
Abstract:
Novel, mesalazine, metronidazole conjugates 6a-e with amino acid linkers were synthesized utilizing benzotriazole chemistry. Biological data acquired for all the novel bis-conjugates showed (a) some bis-conjugates exhibit comparable anti-inflammatory activity with parent drugs and (b) the potent bis-conjugates show no visible stomach lesions. 3D-pharmacophore and 2D-QSAR modeling support the observed bio-properties.
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
Drug Metabolism: Phase II Reactions
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Cholinergic Antagonists: Pharmacokinetics
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

